ARCHIVES

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

This article is from The Cancer Letter archive.

Vol. 05 No. 45 | November 9, 1979

Download PDF Visit The Full Archive

Related Articles

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

Six NY Institutes Form Cancer Vaccine Collaboration

November 8, 2002

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

Organ Systems Program Reorganization Complete; Annual Conferences To Replace Working Groups

May 26, 1989

Fruits, Vegetables Protective Against Cancer, IARC Says

May 30, 2003